PURE Bioscience Inc (OTCPK:PURE)
$ 0.0951 -0.006 (-5.93%) Market Cap: 10.64 Mil Enterprise Value: 13.91 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 31/100

Q3 2019 PURE Biosciences Inc Earnings Call Transcript

Jun 13, 2019 / 08:30PM GMT
Release Date Price: $0.48 (+11.63%)
Operator

Thank you for standing by. This is the conference operator. Welcome to the PURE Bioscience Q3 2019 Results Conference Call. (Operator Instructions) And the conference is being recorded. (Operator Instructions)

I would now like to turn the conference over to Terri MacInnis, Vice President of Investor Relations at Bibicoff + MacInnis, Inc. Go ahead, ma'am.

Terri MacInnis
Bibicoff & Macinnis, Inc. - VP of IR

Thank you, Karl, and good afternoon, everyone. I'm pleased to welcome you to the company's conference call to discuss fiscal 2019 Q3 and 9 months financial and operating results and an update on PURE's food safety business strategy.

On our call is Hank Lambert, Chief Executive Officer; and Mark Elliott, VP, Finance. They are joined today by Tom Myers, Chief Operating Officer.

This afternoon, PURE issued a financial results news release and filed its fiscal Q3 report on Form 10-Q, copies of which are available on the SEC's website and the Investor Relations page of PURE's website, purebio.com. This call is being webcast live

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot